NCT05557357

Brief Summary

This randomized controlled trial aims to evaluate the efficacy and safety of either electroacupuncture alone or combined with warm needling in reducing tinnitus loudness and improving the impairment caused by tinnitus in Hong Kong.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
90

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Dec 2022

Geographic Reach
1 country

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 18, 2022

Completed
10 days until next milestone

First Posted

Study publicly available on registry

September 28, 2022

Completed
2 months until next milestone

Study Start

First participant enrolled

December 1, 2022

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 12, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 12, 2024

Completed
Last Updated

May 25, 2025

Status Verified

May 1, 2025

Enrollment Period

1.4 years

First QC Date

September 18, 2022

Last Update Submit

May 21, 2025

Conditions

Keywords

TinnitusAcupunctureMoxibustionWarm NeedlingClinical TrialRandomized Controlled Trial

Outcome Measures

Primary Outcomes (1)

  • Change in Tinnitus Loudness

    A 0-10 numeric rating scale (NRS) will be used for rating loudness of tinnitus. Higher score indicates greater tinnitus loudness and its influence.

    Baseline, Week 5, and Week 10

Secondary Outcomes (1)

  • Change in Tinnitus Handicap Inventory (THI)

    Baseline, Week 5, and Week 10

Other Outcomes (1)

  • Adverse Events

    Up to 10 weeks

Study Arms (3)

EA Group

EXPERIMENTAL

Subjects assigned to EA group will receive EA treatment twice weekly for 5 weeks.

Procedure: Electroacupuncture (EA)

EAWN Group

EXPERIMENTAL

Subjects assigned to EAWN group will receive EAWN treatment twice weekly for 5 weeks.

Procedure: Electroacupuncture Combined With Warm Needling (EAWN)

Waitlist Control Group

OTHER

Subjects assigned to waitlist control group will not receive treatment during the 10-week waiting period after baseline assessment.

Other: Waitlist Control

Interventions

Electroacupuncture (EA) treatment following standardized procedures will be conducted for 2 sessions per week for 5 consecutive weeks. Each session of treatment will last for 25 min. The acupoints that will be stimulated are Tinggong (SI19) and Yifeng (TE17) of the affected side, Baihui (GV20) and Yintang (GV24+), bilateral posterior temporal line (MS11), and Zhongzhu (TE3) and Zusanli (ST36) of the affected side. For electroacupuncture (EA), electrical stimulation will be applied using an EA apparatus, with pairs of electrodes connecting the needles at ipsilateral SI19 and TE17, GV20 and GV24+, and bilateral MS11.

EA Group

Electroacupuncture combined with warm needling (EAWN) treatment following standardized procedures will be conducted for 2 sessions per week for 5 consecutive weeks. Each session of treatment will last for 25 min. The acupoints that will be stimulated are SI19 and TE17 (affected side), GV20 and GV24+, bilateral MS11, and TE3 and ST36 (affected side). For electroacupuncture (EA), electrical stimulation will be applied using an EA apparatus, with pairs of electrodes connecting the needles at ipsilateral SI19 and TE17, GV20 and GV24+, and bilateral MS11. For warm needling (WN), two moxa sticks will be ignited and attached one by one to the needle handle of each acupoint of SI19 and TE17.

EAWN Group

No treatment will be provided during the 10-week waiting period after baseline assessment.

Waitlist Control Group

Eligibility Criteria

Age50 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosed with subjective tinnitus;
  • Male and female, age 50 to 70 years old;
  • Unilateral or bilateral tinnitus for 0.5-24 months;
  • Loudness of tinnitus rated 3 points or more on a 0-10 numeric rating scale (NRS) at the time of enrollment; and
  • Agree to sign the informed consent form voluntarily.

You may not qualify if:

  • Known disease conditions that could cause tinnitus such as Meniere's syndrome, acoustic duct diseases, and middle ear diseases;
  • History of head trauma;
  • Currently using cardiac pacemaker or metal implants;
  • Known severe cardiac diseases, cerebrovascular diseases, renal diseases, or hematologic diseases;
  • Known severe psychiatric or psychological disorder;
  • Pregnant, lactation or expecting a pregnancy during the study period;
  • Severe needle phobia;
  • Known hypersensitive reaction after acupuncture and moxibustion treatment or an inability to cooperate with the acupuncture and moxibustion procedure;
  • Incapable to understand and answer the questions of the assessors in the study; and

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Pok Oi Hospital-Chinese Medicine Polyclinic (Tin Shui Wai)

Hong Kong, China

Location

Pok Oi Hospital-The Chinese University of Hong Kong Chinese Medicine Clinic cum Training ad Research Centre (Yuen Long District)

Hong Kong, China

Location

Pok Oi Hospital-The Chinese University of Hong Kong Chinese Medicine Clinic cum Training and Research Centre (Shatin District)

Hong Kong, China

Location

MeSH Terms

Conditions

Tinnitus

Interventions

Electroacupuncture

Condition Hierarchy (Ancestors)

Hearing DisordersEar DiseasesOtorhinolaryngologic DiseasesSensation DisordersNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Combined Modality TherapyTherapeuticsAcupuncture TherapyComplementary TherapiesElectric Stimulation TherapyPhysical Therapy ModalitiesRehabilitationTranscutaneous Electric Nerve StimulationAnalgesiaAnesthesia and AnalgesiaAnesthesia

Study Officials

  • Yuanqi GUO

    Pok Oi Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Chinese Medicine Practitioner I

Study Record Dates

First Submitted

September 18, 2022

First Posted

September 28, 2022

Study Start

December 1, 2022

Primary Completion

April 12, 2024

Study Completion

April 12, 2024

Last Updated

May 25, 2025

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will not share

Locations